| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/06/2005 | US20050005325 Mutant fatty acid desaturase and methods for directed mutagenesis |
| 01/06/2005 | US20050005324 Gene promoters isolated from potato and use thereof |
| 01/06/2005 | US20050005323 Using expression vector comprising nucleotide sequences coding sucrose isomerase as tool in generating transgenic plants with increased carbohydrate concentration; for use in fermenting compounds such as methanol, ethanol and 1,3 propandiol |
| 01/06/2005 | US20050005322 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 01/06/2005 | US20050005320 Transforming plants with nucleotide sequences coding phytochrome A for use as tool in controlling high pigment (hp-1) protein expression and increasing the phytonutrient and/or chlorophyll content and/or yield of a crop |
| 01/06/2005 | US20050005319 Generating conditionally lethal nicotiana or arabidopsis models for use tools in identifying preferential gene function; generating herbicide, insect and disease resistance in plants |
| 01/06/2005 | US20050005318 Using micromanipulation and microtubule inhibitors to enucleate oocytes; generating cloned animal embryos for use in treatment and prevention nervous sytem disorders and heart disease; in vitro fertilization |
| 01/06/2005 | US20050005317 Expression of zebrafish bone morphogenetic protein 4 |
| 01/06/2005 | US20050005315 Animals with high histamine productivity |
| 01/06/2005 | US20050005314 Animal model comprising constitutively exprressed anaplastic lymphoma kinase (ALK) gene for use in identifying agents which prevent and treat tumor metastasis; gene expression inhibition; RNA interference; immunotherapy |
| 01/06/2005 | US20050005313 Using magnetic resonance imaging to identify tagged tumor marker sequences; prepariing and using antisense agents as therapeutic tools in treatment of cell proliferative disorders; immunotherapy |
| 01/06/2005 | US20050005312 Propagation of human hepatocytes in non-human animals |
| 01/06/2005 | US20050005310 Expression vectors and methods |
| 01/06/2005 | US20050004355 Diagnosing immune system disorders using defensin specific immuoglobulin; microbiocides and treatment of respiratory system disorders |
| 01/06/2005 | US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use |
| 01/06/2005 | US20050004351 Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same |
| 01/06/2005 | US20050004350 Novel chemiluminescent reagents |
| 01/06/2005 | US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia |
| 01/06/2005 | US20050004347 Protein logic gates |
| 01/06/2005 | US20050004346 Recombinant anti-plasmodium falciparum antibodies |
| 01/06/2005 | US20050004165 Composition and method for modulating BAR/FXR receptor activity |
| 01/06/2005 | US20050004067 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 01/06/2005 | US20050004064 Method of inhibiting gene expression |
| 01/06/2005 | US20050004063 nucleotide sequence which was designed based on portions of the genomic sequences of the different strains of the hSARS virus and their use as therapeutic agents in therapeutic methods |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004059 Gene amplification and overexpression in cancer |
| 01/06/2005 | US20050004058 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 01/06/2005 | US20050004056 Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis |
| 01/06/2005 | US20050004055 Synergistic process; electrical stimulation; administering hyaluronidase |
| 01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 01/06/2005 | US20050004034 Human C-Maf compositions and methods of use therefor |
| 01/06/2005 | US20050004028 modulating cell growth, cell differentiation, or cell survival; genetic engineering using hedgehog genes and proteins; neurodegenerative diseases; tissue-targeted therapy |
| 01/06/2005 | US20050004021 Enzyme inhibitor for therapy of thrombosis, blood disorders |
| 01/06/2005 | US20050004019 Neuroprotective peptides and uses thereof |
| 01/06/2005 | US20050004015 Novel haemopoietin receptor and genetic sequences encoding same |
| 01/06/2005 | US20050004008 Determining metastatic of cancer using concentration of phosphorylated adaptor protein; anticancer agenst |
| 01/06/2005 | US20050003986 Mutants in subtilisin gene; detergents; oxidation resistance |
| 01/06/2005 | US20050003985 From Bacillus; hybrid protein; detergents, cleaning compounds |
| 01/06/2005 | US20050003556 Probe Beads for affirnity reaction and detection system |
| 01/06/2005 | US20050003549 Nucleotide sequences coding methyltransferase for use in identifying modulators for treatment of respiratory disorders in cattle; veterinary medicine |
| 01/06/2005 | US20050003548 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 01/06/2005 | US20050003547 Compositions and methods for tissue specific targeting of lentivirus vectors |
| 01/06/2005 | US20050003546 Viral uptake into cells and tissues |
| 01/06/2005 | US20050003545 Transgenic cells comprising plasmid for use as tool in heterologous gene delivery and cancer treatment |
| 01/06/2005 | US20050003543 Methods of modifying genes in eukaryotic cells |
| 01/06/2005 | US20050003542 Enhanced sleeping beauty transposon system and methods for using the same |
| 01/06/2005 | US20050003541 Transgenic embryonic stem cells comprising vector coding RNA interfering sequences for use in generating gene knockout animal models; gene expression analysis |
| 01/06/2005 | US20050003540 Altered recombinases for genome modification |
| 01/06/2005 | US20050003539 Plasmid maintenance system for antigen delivery |
| 01/06/2005 | US20050003538 Double-transfected cell line useful for the identification of transport inhibitors |
| 01/06/2005 | US20050003536 Method and system for rapidly conferring a desired trait to an organism |
| 01/06/2005 | US20050003526 Preparing porcine stem cell cultures via inoculating nutrient broth comprising stem cell factor and interleukins with bone marrow and/or fetal liver stem cells; for use in identifying therapeutiic agents for treatment of allergenic and hypersensitivity disorders |
| 01/06/2005 | US20050003512 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/06/2005 | US20050003511 Expression vector comprising pi replicon and f factor orgin of replication gene sequences for use as tools in selective cloning and/or manipulation of large regions of DNA; heterologous gene transfer and expression |
| 01/06/2005 | US20050003510 Transgenic lactobacillus which has been modified to express heterologous gene products on cell wall surface for use as therapeutic tool in prevention of bacterial infection and inflammatory response |
| 01/06/2005 | US20050003506 Viral packaging cells for use as gene transfer and expression tools in genetic engineering; bioreactor |
| 01/06/2005 | US20050003505 delivering genes; gag genes, gag protein; endothelial growth factor |
| 01/06/2005 | US20050003504 Alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning products comprising said alkaline protease |
| 01/06/2005 | US20050003500 Producing optically active vicinal diols via reacting (2S,3S)-2,3-butanediol dehydrogenase, microorganism, 2,3-butanedione and (2S,3S)-2,3-butanediol in presence of reduced nicotinamide adenine dinucleotides; for use as raw material in flavors and pharmeceuticals |
| 01/06/2005 | US20050003495 Method for producing L-lysine or L-arginine by using methanol-assimilating bacterium |
| 01/06/2005 | US20050003494 Mutated gene from corynebacterium glutamicum |
| 01/06/2005 | US20050003492 Novel polypeptide |
| 01/06/2005 | US20050003490 Immunoglobulins specific for cell surface protein for use in diagnosis, prevention and treatment of cell proliferative disorders; inhibitory action associated with reduced cellular transport of amino acids |
| 01/06/2005 | US20050003489 Conformational and topological protein regulation |
| 01/06/2005 | US20050003485 Method for recombinant production of polypeptides |
| 01/06/2005 | US20050003484 Modified antigen-presenting cells |
| 01/06/2005 | US20050003482 Expression vector comprising nucleotide sequences coding foot and mouth viral, as well as, immunoglobulin sequences for use in generation imunotherapeutics |
| 01/06/2005 | US20050003481 Novel glutamic acid receptor and utilization thereof |
| 01/06/2005 | US20050003479 MtHP promoter element |
| 01/06/2005 | US20050003478 Transforming pasturella with expression vector comprising nucleotide sequences coding acetylglucosaminyltransferase; bioreactors |
| 01/06/2005 | US20050003476 Nove glycosyltransferase genes |
| 01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 01/06/2005 | US20050003463 Method and nucleic acids for the analysis of colorectal cell proliferative disorders |
| 01/06/2005 | US20050003460 Identifying progenitor cell populations comprising at least one disaccharide repeat of glucuronic acid and n-acetylglucosamine and enhanced hyaluronic acid synthase expression for use in tissue repair and treatment and prevention of cancer and/or skin disorders. |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003454 Conformational and topological protein regulation |
| 01/06/2005 | US20050003453 G-CSF analog compositions and methods |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003446 Peptide sequences for use in identification of modulators for use in treatment and prevention of inflammatory, cell proliferative, arteriosclerotic and skin disorders |
| 01/06/2005 | US20050003445 Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| 01/06/2005 | US20050003442 Delta4-desaturase genes and uses thereof |
| 01/06/2005 | US20050003441 Methods and compositions for amplification of RNA sequences |
| 01/06/2005 | US20050003439 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 01/06/2005 | US20050003438 Conformational and topological protein regulation |
| 01/06/2005 | US20050003437 Human oncogene induced secreted protein I |
| 01/06/2005 | US20050003436 Release of intracellular material |
| 01/06/2005 | US20050003433 Recombinant neospora antigens and their uses |
| 01/06/2005 | US20050003428 Solid compositions for selective adsorption from complex mixtures |
| 01/06/2005 | US20050003426 Nucleotide sequences coding zinc finger protein comprising repeat sequences for use as tool in diagnosing and treating muscular disorders |
| 01/06/2005 | US20050003423 Expression vector comprising polynucleotide sequences coding transcriptional regulator associated with lysine biosynthesis for use in generation of transgenic bacterial cells with enhanced lysine biosynthesis; for enhancing animal feeds, cosmetics and medicines |
| 01/06/2005 | US20050003419 Enhanced enzymatic polypeptide for use as component of cleaning compound; detergents; papermaking; textiles |
| 01/06/2005 | US20050003416 Novel modified corin molecules having substitute activation sequences and uses thereof |
| 01/06/2005 | US20050003412 Protein activator of superoxide production for use in treatment and prevention of cancer, psoriasis, prostatic hypertrophy, benign prostatic hypertrophy and cardiovascular disease |
| 01/06/2005 | US20050003409 Expression vector comprising nucleotide sequences coding polyketide synthase for use in transformation, and propagation of streptomyces cells capable of producing moxidectin; bactericides; nematocide |
| 01/06/2005 | US20050003408 Libraries of oligomers labeled with different tags |
| 01/06/2005 | US20050003407 Genomic DNA fragments containing regulatory and coding sequence for the beta2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments |
| 01/06/2005 | US20050003404 Telomerase interference |
| 01/06/2005 | US20050003403 Multimeric protien for use in treatment and prevention of infections, nervous system, inflammatory, autoimmune and cell proliferative disorders |
| 01/06/2005 | US20050003401 Expression vector comprising nucleotide sequences coding archaeal replication factor A (RFA) for use in generating polypeptide which enhances stability and efficacy of gene amplification products |
| 01/06/2005 | US20050003400 Using osteoprotegrin binding agent as tool in identifying modulator for treatment and prevention of osteoporosis and bone disorders |